Cargando…

Can sPD-1 and sPD-L1 Plasma Concentrations Predict Treatment Response among Patients with Extraparenchymal Neurocysticercosis?

Extraparenchymal neurocysticercosis (EP-NC) is a chronic, potentially life-threatening disease that responds poorly to initial anthelmintic drug therapy. A depressed specific reactivity of peripheral lymphocytes and an increased level of specific Tregs accompanies EP-NC. The immune checkpoint pathwa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toledo, Andrea, Fragoso, Gladis, Carrillo-Mezo, Roger, Romo, Matthew L., Sciutto, Edda, Fleury, Agnès
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535301/ https://www.ncbi.nlm.nih.gov/pubmed/37764924 http://dx.doi.org/10.3390/pathogens12091116

Ejemplares similares

Low responsiveness of peripheral lymphocytes in extraparenchymal neurocysticercosis
por: Romo, Matthew L., et al.
Publicado: (2023)

Human Extraparenchymal Neurocysticercosis: The Control of Inflammation Favors the Host…but Also the Parasite
por: Toledo, Andrea, et al.
Publicado: (2018)

Extraparenchymal neurocysticercosis: Demographic, clinicoradiological, and inflammatory features
por: Marcin Sierra, Mariana, et al.
Publicado: (2017)

Standardizing an Experimental Murine Model of Extraparenchymal Neurocysticercosis That Immunologically Resembles Human Infection
por: Espinosa-Cerón, Alejandro, et al.
Publicado: (2023)

Soluble programmed death-1 (sPD-1) and programmed death ligand 1 (sPD-L1) as potential biomarkers for the diagnosis and prognosis of glioma patients
por: Liu, Shujun, et al.
Publicado: (2020)

Clinical Relevance of Soluble Forms of Immune Checkpoint Molecules sPD-1, sPD-L1, and sCTLA-4 in the Diagnosis and Prognosis of Ovarian Cancer
por: Świderska, Janina, et al.
Publicado: (2022)

The correlation of serum sPD-1 and sPD-L1 levels with clinical, pathological characteristics and lymph node metastasis in nonsmall cell lung cancer patients
por: ANCIN, Burcu, et al.
Publicado: (2022)

The association between sPD-1 levels versus liver biochemistry and viral markers in chronic hepatitis B patients: a comparative study of different sPD-1 assays
por: Jeng, Wen-Juei, et al.
Publicado: (2022)

Soluble Programmed Death Receptor Ligands sPD-L1 and sPD-L2 as Liquid Biopsy Markers for Prognosis and Platinum Response in Epithelial Ovarian Cancer
por: Buderath, Paul, et al.
Publicado: (2019)

The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma
por: Chang, Boyang, et al.
Publicado: (2018)

Reversible manifestations of extraparenchymal neurocysticercosis
por: Campos, Edison M., et al.
Publicado: (2018)

Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series
por: Cárdenas, Graciela, et al.
Publicado: (2010)

Upregulation of PD-1 Expression and High sPD-L1 Levels Associated with COVID-19 Severity
por: Beserra, Danielle Rosa, et al.
Publicado: (2022)

Neurocysticercosis: HP10 Antigen Detection Is Useful for the Follow-up of the Severe Patients
por: Fleury, Agnès, et al.
Publicado: (2013)

Correlation of sPD1 with Procalcitonin and C-Reactive Protein Levels in Patients with Sepsis
por: Bakhshiani, Zahra, et al.
Publicado: (2021)

Soluble sPD-L1 and Serum Amyloid A1 as Potential Biomarkers for Lung Cancer
por: Jovanović, Dragana, et al.
Publicado: (2019)

The Clinical Significance of Soluble Programmed Cell Death-Ligand 1 (sPD-L1) in Patients With Gliomas
por: Liu, Shujun, et al.
Publicado: (2020)

Serum sPD1 and sPDL1 as Biomarkers for Evaluating the Immune State of Lung Adenocarcinoma Patients
por: Wu, Yumin, et al.
Publicado: (2022)

Backsplash Testbeam results for the SPD
por: Aguiló, E, et al.
Publicado: (2004)

Backsplash simulation and occupancies for the SPD
por: Aguiló, E, et al.
Publicado: (2003)

Molecular Mechanism of Expression Changes of Immunological Indexes of PD-1/sPD-L1 after Radiotherapy in Nonsmall Cell Lung Cancer
por: Qu, Yanli, et al.
Publicado: (2021)

Extraparenchymal neurocysticercosis in the United States: a case report
por: Kelesidis, Theodoros, et al.
Publicado: (2011)

“Role of kidney function and concentrations of BAFF, sPD-L1 and sCD25 on mortality in hospitalized patients with COVID-19”
por: Mansouri, Ladan, et al.
Publicado: (2022)

Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice
por: Tan, Yandi, et al.
Publicado: (2021)

Soluble programmed death molecule 1 (sPD-1) as a predictor of interstitial lung disease in rheumatoid arthritis
por: Xu, Li, et al.
Publicado: (2021)

The potential of soluble programmed death-ligand 1 (sPD-L1) as a diagnosis marker for colorectal cancer
por: Shao, Weifang, et al.
Publicado: (2022)

The Change of Soluble Programmed Death Ligand 1 (sPD-L1) in Plasma of Small Cell Lung Cancer and Its Clinical Significance
por: Lu, Feijie, et al.
Publicado: (2022)

The clinical implication of soluble PD-L1 (sPD-L1) in patients with breast cancer and its biological function in regulating the function of T lymphocyte
por: Han, Baojuan, et al.
Publicado: (2021)

Pulseshape simulations for the SPD subdetector in LHCb
por: Aguiló, E
Publicado: (2004)

Backsplash simulation for the SPD (LHCb subdetector)
por: Calvo, M
Publicado: (2004)

A BICMOS discriminator interface for the SPD
por: Diéguez, A, et al.
Publicado: (2000)

The ALICE Silicon Pixel Detector (SPD)
por: Meddi, F
Publicado: (2000)

SPD Very Front End Electronics
por: Luengo, Sonia, et al.
Publicado: (2005)

Backsplash studies for the SPD subdetector of LHCb
por: Calvo-Gomez, Miriam
Publicado: (2006)

Higher serum sPD-L1 levels after radiotherapy indicate poor outcome in hepatocellular carcinoma patients
por: Zhang, Yang, et al.
Publicado: (2022)

Soluble Programmed Death Ligand-1 (sPD-L1): A Pool of Circulating Proteins Implicated in Health and Diseases
por: Bailly, Christian, et al.
Publicado: (2021)

Retracted: The Change of Soluble Programmed Death Ligand 1 (sPD-L1) in Plasma of Small Cell Lung Cancer and Its Clinical Significance
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Clinical Symptoms, Imaging Features and Cyst Distribution in the Cerebrospinal Fluid Compartments in Patients with Extraparenchymal Neurocysticercosis
por: Bazan, Rodrigo, et al.
Publicado: (2016)

The Caenorhabditis elegans pericentriolar material components SPD-2 and SPD-5 are monomeric in the cytoplasm before incorporation into the PCM matrix
por: Wueseke, Oliver, et al.
Publicado: (2014)

Taenia solium: Development of an Experimental Model of Porcine Neurocysticercosis
por: Fleury, Agnès, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dmhojnpstba2qkpl0e7flse9mc